This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced that it will be attending DCAT Week from March ...

It was business as usual at the recent Drug, Chemical, and Associated Technologies Association’s DCAT Week, an annual affair in New York City at which pharmaceutical services companies meet and strike ...

Peter DeYoung, CEO, Piramal Pharma Solutions, talks about recent company achievements and key offerings, as well as current industry trends. At a recent Drug, Chemical & Associated Technologies (DCAT) ...

Shilpa Medicare has launched its new full service ‘hybrid’ CDMO at DCAT 2025. The newly formed CDMO will see Shilpa serve both small and large molecules customers as well as peptides – with oncology a ...